LIST:
I am very active in the vaccine issue mostly military with the anthrax
vaccine. Please see the posts I have sent to many people. Please inform
others. Now that we are preparing for war, we are getting alot of
considerations for refusal! Its amazing and I stand with them 100%.
Here is what I have sent. Please note the CDC website for pictures of
vaccinated kids reactions. The site worked as of last week so if it doesn't
now than GO FIGURE!
Jane
~ ~ ~ ~ ~ ~ ~
Please send this to at least 7 people on your mailing list.
KNOW THE FACTS BEFORE YOU DO THE SURVEY, a picture is worth
a thousand words, these kids were vaccinated!
http://www.bt.cdc.gov/Agent/Smallpox/VaccineImages2.asp
SOURCE: http://www.philly.com/mld/philly/news/nation/4416863.htm
Posted on Fri, Nov. 01, 2002
Caution on child smallpox tests
The FDA wants to give the public a say before it approves trials of a vaccine
that poses some risk.
By Lauran Neergaard
Associated Press
WASHINGTON - Researchers want to begin the first studies of the effects of a
smallpox vaccine on toddlers and preschoolers - a proposal raising such
thorny questions about safety and ethics that the government is seeking
public reaction before giving the approval.
Among the issues: The vaccine is made of a live virus called vaccinia
that can cause its own infections until the injection site scabs over, so
researchers plan to keep inoculated children out of day care or school for a
month. But will youngsters tear off their bandages and put relatives,
playmates or others at risk?
And is it ethical to test in healthy children a vaccine that could cause
a life-threatening reaction when they probably will not benefit from the
vaccine - unless a bioterrorist attacks with smallpox?
After research oversight boards had mixed reactions, the Food and Drug
Administration announced yesterday that for the next month it will accept
public comment on whether the University of California, Los Angeles, and
Cincinnati Children's Hospital should inoculate 40 2- to 5-year-olds with
smallpox vaccine.
"It is a very challenging issue because there is no smallpox circulating
right now," said Dr. Karen Midthun, the FDA's head of vaccine research.
"There is great concern that there be a lot of safeguards for studies being
conducted in children."
Although smallpox was eradicated in the 1970s, officials fear that
laboratory samples might have fallen into terrorists' hands. Faced with that
uncertainty, the Bush administration is preparing to make a vaccine again
available, first to certain health-care workers and later to the general
public.
It is a difficult decision because of the vaccine's risks: Based on
studies from the 1960s, 15 of every 1 million people vaccinated will suffer
life-threatening reactions, and one or two of them will die.
A vaccinated person can spread the vaccine's virus by touching the
injection site, then touching their eyes or mouth, or someone else. If the
virus spread to the eye, for instance, it could cause blindness. Someone with
a weak immune system, such as an AIDS patient, could be killed.
Children once routinely got the smallpox shot, so why is new testing an
issue?
The vaccine has been kept frozen for 30 years. To ensure there are enough
potent shots to go around until new ones are made, scientists are studying
whether diluted doses work. Recent studies in adults suggested they do. The
planned pediatric study, sponsored by the National Institutes of Health,
would test those weaker doses in young children, whose immune systems work
differently than adults' do.
~ ~ ~ ~ ~ ~ ~ ~ ~
Feds seek public input on vaccine
2002-11-01
By Lauran Neergaard
AP Medical Writer
WASHINGTON - The government is seeking public input before it decides whether
to let a few dozen toddlers and preschoolers be vaccinated against smallpox,
a study to test the best children's vaccine dose but one raising thorny
questions about safety and ethics.
The vaccine is made of a live virus called vaccinia that can cause its own
infections until the injection site scabs over, so researchers plan to keep
inoculated children out of day care or school for a month. But still there is
a chance that youngsters could tear off their bandages and put relatives,
playmates or others at risk.
There also is the question of whether it is ethical to test in healthy
children a vaccine that could cause a life-threatening reaction when the
children probably won't benefit from it - unless a bioterrorist attacks with
smallpox.
After research oversight boards reached mixed conclusions on these issues,
the Food and Drug Administration announced Thursday that for the next month
it will accept public comment on whether the University of California, Los
Angeles, and Cincinnati Children's Hospital should inoculate 40 2- to
5-year-olds with smallpox vaccine. They would be the first children to get
the shots since routine vaccination ended in 1972.
It's highly unusual for the FDA to seek public opinion on research.
``It is a very challenging issue because there is no smallpox circulating
right now,'' said Dr. Karen Midthun, the FDA's head of vaccine research.
``There is great concern that there be a lot of safeguards for studies being
conducted in children.''
``This is an unusual time, it's an unusual need and I think the risks are not
totally insignificant,'' said Dr. Joel Ward of UCLA, the lead researcher.
``So I think this extra care is appropriate.''
Although wild smallpox was eradicated in the 1970s, officials fear that
laboratory samples might have fallen into terrorists' hands. Faced with that
uncertainty, the Bush administration is preparing to make vaccine available
again, first to certain health care workers and later to the general public.
It's a difficult decision because of the vaccine's risks. Based on studies
from the 1960s, 15 of every 1 million people vaccinated will suffer
life-threatening reactions, and one or two of them will die.
A vaccinated person can spread the vaccine's virus by touching the injection
site, then touching the eyes, mouth or someone else. If the virus spread to
the eye, for instance, it could cause blindness. Someone with a weak immune
system, such as an AIDS patient, could be killed.
Children once routinely got the smallpox shot, so why is new testing an
issue?
The vaccine has been kept frozen for 30 years. To ensure there are enough
still-potent shots to go around until new ones are made, scientists are
studying whether diluted doses work. Recent studies in adults suggest they
do. The planned pediatric study, sponsored by the National Institutes of
Health, would test those weaker doses in young children, whose immune systems
work differently than adults.
``I would certainly want these trials to be conducted before I would want my
child to be vaccinated,'' said Dr. Julia McMillan of Johns Hopkins
University, a spokeswoman for the American Academy of Pediatrics. The academy
has urged the government since last spring to do child studies before
allowing broad access to the vaccine.
It's not just for the child's benefit, she said. The last time children were
inoculated, their relatives and playmates were too, so no one knows how kids
might spread vaccinia through today's unvaccinated population.
Federal regulations require special oversight for research that poses more
than a minimal risk to a child who won't get a significant benefit. Oversight
panels and independent experts consulted by the government have said that is
the case here, because children's risk of getting smallpox is so small.
Still, most of those experts said the research should be allowed because it
could benefit society. They did suggest changes, such as limiting
inoculations to the children of people enrolled in adult smallpox vaccine
studies, because those parents may better understand the risks. Fully
explaining the risks to parents is crucial, many said.
``Many parents incorrectly believe that the risk of potential exposure (to
smallpox) is very high,'' Johns Hopkins professor Dr. Neal Halsey wrote the
FDA.
Under current study plans, no child would be inoculated if the child or a
family member has immune problems or skin diseases such as eczema that raise
the risk of vaccine complications. Children who live with a pregnant woman or
infant would also be ineligible, because babies under age 1 are at
significantly higher risk of a vaccine-caused brain infection.
Inoculation sites would be covered with a special bandage that in adult
studies proved very effective at preventing spread of the vaccine's virus.
While children are known to rip off bandages, Midthun said this one is extra s
ticky, ``very, very hard to get off.''
--
The silver-list is a moderated forum for discussion of colloidal silver.
Instructions for unsubscribing may be found at: http://silverlist.org
To post, address your message to: [email protected]
Silver-list archive: http://escribe.com/health/thesilverlist/index.html
List maintainer: Mike Devour <[email protected]>